UFT 100mg / 224mg capsules medication leaflet

L01BC53 • tegafur + uracil • Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues

This combination of tegafur and uracil is used for the treatment of certain types of cancer, such as colorectal cancer. Tegafur is a prodrug of 5-fluorouracil (5-FU), while uracil is added to inhibit the degradation of 5-FU, thereby increasing the efficacy of the treatment.

The medication is taken orally, usually twice daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor the response to treatment.

Patients should be aware of potential side effects, such as nausea, diarrhea, or a decrease in blood cell counts. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, diarrhea, fatigue, and loss of appetite. In rare cases, severe reactions such as myelosuppression or gastrointestinal toxicity may occur. Patients should be informed of these risks before starting treatment.